FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055180 [Registered on: 13/07/2023] Trial Registered Prospectively
Last Modified On: 12/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Drakshadi Vati and Durvadi Ghrita matra basti on female menstrual disorder. 
Scientific Title of Study   Effect of Drakshadi vati orally and Durvadi ghrita matrabasti on Pittaja artava dusti- an Exploratory study. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  KAHKASHAN NOOR USMANI 
Designation  PG Scholar 
Affiliation  All India Institute of Ayurveda 
Address  All India Institute of Ayurveda, Gautampuri, Sarita vihar, Fourth floor Academic block, Stri Roga evum Prasuti Tantra Department.

South
DELHI
110076
India 
Phone  7302305728  
Fax    
Email  kahkashannoor3@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sujata kadam 
Designation  Professor 
Affiliation  All India Institute of Ayurveda 
Address  Fourth floor, Academic block, All India Institute of Ayurveda, Gautampuri, Sarita vihar
Fourth floor, Academic block,All India Institute of Ayurveda, Gautampuri, Sarita vihar
South
DELHI
110076
India 
Phone  9890305370  
Fax    
Email  sujatadkadam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sujata kadam 
Designation  Professor 
Affiliation  All India Institute of Ayurveda 
Address  Fourth floor, Academic block, Stri roga evum Prasuti tantra Department, All India Institute of Ayurveda, Gautampuri, Sarita vihar

South
DELHI
110076
India 
Phone  9890305370  
Fax    
Email  sujatadkadam@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Ayurveda, Sarita vihar, New Delhi 
 
Primary Sponsor  
Name  All India Institute Of Ayurveda 
Address  All India Institute of Ayurveda, Gautampuri , Sarita vihar, 110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Kahkashan Noor Usmani  All India Institute of Ayurveda  All India Institute of Ayurveda, Gautampuri , Sarita vihar, 110076 Stri roga evum Prasuti tantra department,
South
DELHI 
7302305728

kahkashannoor3@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N920||Excessive and frequent menstruation with regular cycle. Ayurveda Condition: PITTAJA/ARTAVADUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Durvadi ghrita, Reference: Rasa tantra sara, Route: Rectal, Dosage Form: Ghrita, Dose: 60(ml), Frequency: od, Bhaishajya Kal: 7 Days, Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: Drakshadi vati, Reference: Susruta uttar tantra, Route: Oral, Dosage Form: Ghrita, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: 90 Days, Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Patients suffering from symptoms of Pittaj Artav Dushti.Excreted blood is ho,associated with severe burning sensation and feeling of heat, Dysuria (Pittaj Artava dushti subjects with or without fibroids, polyp, adenomyosis) Patient whose thyroid profile is within normal limits, Patient should be interested and give their consent for the study work.
 
 
ExclusionCriteria 
Details  Malignancy of genital tract, Congenital anomalies of genital tract, Other severe systemic illnes 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in symptoms of pittaja artava dushti.  BT (Baseline)
AT (12 week)
FOLLOW UP (4 week) 
 
Secondary Outcome  
Outcome  TimePoints 
Change in physical parameters of rajas.  BT (Baseline)
AT (12 weeks)
Follow up (4 weeks ) 
change in physical parameters of raja  Bt
AT 
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/08/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   According to doshik predominance sign and symptoms in the patients can be seen. therefore proper knowledge of raja is very much important for planning specific treatment of menstrual disorders according to doshas. as there is no work done on pittaja artava dushti this study will help for planning different treatment modalities for pittaja artava dusti for promising results. 
Close